Communiqués Repligen Corporation

Actions

RGEN

US7599161095

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/06/2024			Varia. 5j.	Varia. 1 janv.
127 ^USD	+3,13%		+3,25%	-29,37%

18/06	REPLIGEN CORPORATION : Guggenheim est neutre	ZM
13/06	Mise à jour sectorielle : Les actions du secteur des soins de santé sont mitigées avant la cloche jeudi	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Broadcom, Korn Ferry rise; Signet Jewelers, Repligen fall, Thursday, 6/13/2024	13/06	AQ
Repligen Announces CEO Transition Plan	13/06	AQ
Repligen Corporation to Present at Upcoming June Investor Conferences	22/05	AQ
Repligen : Investor Presentation May 2024 Presentation	17/05	PU
Repligen Corporation to Present at Upcoming May Investor Conferences	07/05	AQ
Repligen: Q1 Earnings Snapshot	01/05	AQ
Repligen Reports First Quarter 2024 Financial Results	01/05	AQ
Repligen to Report First Quarter 2024 Financial Results	17/04	AQ
Repligen : Investor Presentation April 2024 Presentations	02/04	PU
Repligen Appoints Maggie A. Pax to Board of Directors	19/03	AQ
Repligen: Q4 Earnings Snapshot	21/02	AQ
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results	21/02	AQ
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results	07/02	AQ
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference	19/12	AQ
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements	07/12	AQ
Repligen Announces Publication of the Company s 2022 Sustainability Report	15/11	AQ
Repligen Announces Publication of the Company’s 2022 Sustainability Report	14/11	AQ
Repligen Corporation to Present at Upcoming Investor Conferences	07/11	AQ
Repligen Launches TangenX SC as First-to-Market Holder-Free Self-Contained TFF Device	03/11	AQ
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device	02/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Repligen Corporation

Actions

RGEN

US7599161095

Communiqués

Filtres